Nervgen Pharma NGEN Ratios (2024-2026)

NASDAQ NGEN
$1.52 -0.02 (-1.29%)
As of: Oct 21, 2026 · 11:19 AM EDT
Reported Financials

Nervgen Pharma Quarterly Ratios

Periods 6 quarters
Latest Jun 2026

Nervgen Pharma ratios data for the quarter ended Jun 2026. These financial ratios cover 6 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2024 Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 15.93M39.19M
Equity AverageEquity Avg. 3.26M8.07M
Invested CapitalInvested Cap. 1.86M2.54M
Leverage & Solvency
Debt Ratio 0.000.00
Valuation
Price to BookP/B 85.39175.6875.4713.49
Enterprise Value 141.29M140.67M177.24M429.92M288.39M103.00M
Market Capitalization 153.33M140.67M177.24M446.04M300.28M164.08M

Nervgen Pharma Ratios API

Pull Nervgen Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NGEN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY